Akoustis Technologies Inc Stock
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Akoustis Technologies Inc stock is not clear.
With a target price of 28 € there is potential for a 5599900.0% increase which would mean more than doubling the current price of 0.0 € for Akoustis Technologies Inc.
Our community identified positive and negative aspects for Akoustis Technologies Inc stock for the coming years. 1 users see the criterium "EBIT Margin" as a plus for the Akoustis Technologies Inc stock. On the other hand our users think that "Credit Rating" could be a problem in the future.
Pros and Cons of Akoustis Technologies Inc in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Akoustis Technologies Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Akoustis Technologies Inc | - | - | - | - | - | - | - |
| Asure Software | 0.000% | 0.000% | -7.643% | -9.938% | -8.228% | -49.301% | 11.538% |
| Overstock.com | -3.670% | -0.224% | -3.093% | 6.085% | -13.708% | -76.881% | -93.346% |
| Egain Communications | 0.830% | -9.023% | -24.375% | 49.752% | -29.240% | -12.319% | -24.375% |
Comments
Aktis Oncology (AKTS) had its price target raised by HC Wainwright from $30.00 to $33.00. They now have a "buy" rating on the stock.
Show more
Ratings data for AKTS provided by MarketBeat